Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, is a liver condition involving fat buildup and inflammation that can lead to liver damage.
Tekton Research is currently enrolling participants in research studies evaluating investigational medications for MASH.
Participating in a clinical trial may help you:
- Learn more about your condition
- Advance medical discoveries
- Access investigational therapies at no cost
- Receive compensation for time and travel expenses
Most studies provide compensation for time and travel costs. Health insurance is generally not needed to join a clinical trial.
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.